Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hospital centralized safety monitoring of Shenkang Injection after marketing
ChiCTR2100048425Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Jul 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of shenkang, sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoint: Adverse Drug Reactions/Events. Started Jul 2021; status: recruiting.
02
Drugs
shenkang
Beyond the preview
Go deeper on ChiCTR2100048425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048425.